Related Experiment Videos
[Epstein-Barr virus replication in Hodgkin disease]
F Bibeau1, P Brousset, H Knecht
1Laboratoire d'anatomie pathologique, CHU de Purpan, Toulouse, France.
Bulletin Du Cancer
|February 1, 1994
Summary
Epstein-Barr virus (EBV) replication in Hodgkin's disease (HD) is rare, occurring in a small fraction of tumor cells. This study found evidence of EBV replication in a few cases, suggesting abortive lytic cycles and offering insights into viral latency control.
Area of Science:
- Virology
- Oncology
- Immunology
Context:
- Epstein-Barr virus (EBV) is associated with a significant proportion of Hodgkin's disease (HD) cases.
- EBV genomes typically remain latent within Reed-Sternberg (RS) cells in HD.
- Recent findings suggest potential EBV replication activation in some EBV-positive HD cases.
Purpose:
- To investigate the occurrence and characteristics of Epstein-Barr virus (EBV) replication in Hodgkin's disease (HD) tumor cells.
- To examine the expression of viral proteins (Zebra, EA-R) and transcripts (BLLF1) indicative of EBV replication in EBV-positive HD cases.
Summary:
- Fifty Hodgkin's disease (HD) cases with EBV genomes and LMP1 expression were analyzed for Zebra protein using immunohistochemistry.
- Four cases (all HIV-negative) showed Zebra-positive tumor cells, with one case exhibiting numerous Zebra+ cells, EA-R positivity, and strong in situ hybridization signals.
- This specific case confirmed EBV replication through BLLF1 transcript detection via RT-PCR, indicating an abortive lytic cycle in a small subset of RS cells.
Impact:
- EBV replication in RS cells is an exceptional event in HD, providing potential insights into the immune system's control of viral latency.
- The findings suggest that while EBV replication is rare, its detection may offer new avenues for understanding HD pathogenesis.
- Further research is needed to explore the clinical implications of EBV replication in Hodgkin's disease.